Ledger.Open graph →
SEC Form D · filed January 17, 2020

INNOVATE BIOPHARMACEUTICALS, INC

Offering
$2.8M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Arnar Agnarsson · Bozeman, MTDirectorJay P. Madan · Raleigh, NCExec · DirectorSaira K. Ramasastry · Raleigh, NCDirectorLorne Thomas · Odessa, FLExec · DirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorChristopher Long · Mission Woods, KSDirectorLorin K. Johnson · Raleigh, NCDirectorRyan Belanger-Saleh · New York, NYDirectorScott Zeilinger · New York, NYExec · DirectorEdward J. Sitar · Raleigh, NCExecShinji Kim · SAN FRANCISCO, CADirectorJohn Bykowski · Hayward, CAExec · DirectorWilliam P. Corry · Sewickley, PADirectorRoy K. Proujansky · Raleigh, NCDirectorAnthony Maida · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorEdward J. Sitar · Raleigh, NCExecJeffrey Myers · New York, NYDirectorKevin Cavenaugh · Portland, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗